Makoto Suematsu

President, Japan Agency for Medical Research and Development

1983, graduate, and 1988, PhD in Gastroenterology and Microvascular Physiology, Keio University School of Medicine; 1991, Bioengineer Step IV, Institute for Biomedical Engineering, University of California San Diego. April 2001, Professor and Chair, Department of Biochemistry and Integrative Medical Biology, Keio University School of Medicine. June 2007, Leader, Global Center of Excellence for Life Sciences, Human Metabolomic Systems Biology from MEXT. October 2007 - March 2015, Dean, School of Medicine, Keio University. October 2009 - March 2016, Leader, JST, ERATO, Suematsu Gas Biology Project. Since April 2015, Founding President, Japan Agency for Medical Research and Development (AMED). Official Member, Heads of International Research Organizations (HIROs). Treasurer, Global Alliance of Chronic Diseases (GACD). Member: International Selection Panel, National Institute of Health Research Biomedical Research Centres & Units, UK; Funder Committee, Consortium Assembly, International Rare Disease Research Consortium (IRDiRC); International Advisory Board, Vilnius University Faculty of Medicine, Lithuania. Former: President, Japanese Society for Microcirculation; Ludwig Boltzmann Lecturer. President, 10th World Congress for Microcirculation (Kyoto, September 2015). Recipient, Cross of Officer of the Order for Merits to Lithuania (2018). Main research interests: gas biology and medicine, microcirculatory physiology, development of imaging MS spectrometry, exploring disease-specific biomarker molecules by metabolomics.